Orieta Celiku

1.0k total citations
41 papers, 558 citations indexed

About

Orieta Celiku is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Orieta Celiku has authored 41 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Genetics and 9 papers in Cancer Research. Recurrent topics in Orieta Celiku's work include Glioma Diagnosis and Treatment (13 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Orieta Celiku is often cited by papers focused on Glioma Diagnosis and Treatment (13 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Orieta Celiku collaborates with scholars based in United States, Germany and Finland. Orieta Celiku's co-authors include Mark R. Gilbert, Uma Shankavaram, Chunzhang Yang, Bradley Schmerl, David Garlan, Kevin Camphausen, Aiguo Li, Shuping Zhao, Yanxin Lu and Yang Liu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Orieta Celiku

34 papers receiving 552 citations

Peers

Countries citing papers authored by Orieta Celiku

Since Specialization

Citations

This map shows the geographic impact of Orieta Celiku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orieta Celiku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orieta Celiku more than expected).

Fields of papers citing papers by Orieta Celiku

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orieta Celiku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orieta Celiku. The network helps show where Orieta Celiku may publish in the future.

Co-authorship network of co-authors of Orieta Celiku

This figure shows the co-authorship network connecting the top 25 collaborators of Orieta Celiku. A scholar is included among the top collaborators of Orieta Celiku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orieta Celiku. Orieta Celiku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Beyond the Promoter: Total MGMT Gene Methylation Modulates Response to DNA-Alkylating Agents in Glioma 2025 ·Molecular Cancer Therapeutics ·(unknown), Jinkyu Jung, (unknown), Chunzhang Yang, Mioara Larion, Lőrinc Sándor Pongor, Fathi Elloumi, Sudhir Varma, William C. Reinhold, Yves Pommier, Mark R. Gilbert, Orieta Celiku	1
2	The impact of neighborhood-level disadvantage on symptoms, mood, and health-related quality of life among the primary brain tumor population 2025 ·Neuro-Oncology Practice ·(unknown), Kimberly Robins, Orieta Celiku, Yeon-Ju Kim, (unknown), (unknown), Jacqueline B. Vo, Mark R. Gilbert, Terri S. Armstrong, (unknown)	1
3	Symptom Network Analysis and Unsupervised Clustering of Oncology Patients Identifies Drivers of Symptom Burden and Patient Subgroups With Distinct Symptom Patterns 2024 ·Cancer Medicine ·(unknown), Terri S. Armstrong, Yvette P. Conley, Bruce A. Cooper, Marilyn J. Hammer, Jon D. Levine, Steven M. Paul, Christine Miaskowski, Orieta Celiku	3
4	Cysteamine Suppresses Cancer Cell Invasion and Migration in Glioblastoma through Inhibition of Matrix Metalloproteinase Activity 2024 ·Cancers ·Jinkyu Jung, Orieta Celiku, Benjamin I. Rubin, Mark R. Gilbert	1
5	PRONA: an R-package for Patient Reported Outcomes Network Analysis 2024 ·Bioinformatics ·(unknown), Orieta Celiku	0
6	Disparities in the availability of and access to neuro-oncology trial-supporting infrastructure in the United States 2024 ·JNCI Journal of the National Cancer Institute ·(unknown), Terri S. Armstrong, Mark R. Gilbert, Orieta Celiku	1
7	DISP-15. DISPARITIES IN THE AVAILABILITY OF NEURO-ONCOLOGY CLINICAL TRIAL SUPPORTING INFRASTRUCTURE IN THE UNITED STATES 2023 ·Neuro-Oncology ·(unknown), Terri S. Armstrong, Mark R. Gilbert, Orieta Celiku	0
8	Clinical outcome assessment trends in clinical trials—Contrasting oncology and non‐oncology trials 2023 ·Cancer Medicine ·(unknown), Mark R. Gilbert, Terri S. Armstrong, Orieta Celiku	6
9	Histological analysis of sleep and circadian brain circuitry in cranial radiation-induced hypersomnolence (C-RIH) mouse model 2022 ·Scientific Reports ·Dorela D. Shuboni‐Mulligan, (unknown), (unknown), (unknown), Orieta Celiku, Amanda King, Jeeva Munasinghe, Herui Wang, (unknown), Mark R. Gilbert, Dee Dee Smart, Terri S. Armstrong	3
10	Molecularly Targeted Clinical Trials 2021 ·Neurosurgery Clinics of North America ·Matthew Smith-Cohn, Orieta Celiku, Mark R. Gilbert	5
11	IDH1 mutations induce organelle defects via dysregulated phospholipids 2021 ·Nature Communications ·Adrian Lita, Artem Pliss, Andrey N. Kuzmin, Tomohiro Yamasaki, Lumin Zhang, Tyrone Dowdy, (unknown), Natalia de Val, Orieta Celiku, Victor Ruiz‐Rodado, Elena‐Raluca Nicoli, Michael J. Kruhlak, Þorkell Andrésson, Sudipto Das, Chunzhang Yang, (unknown), Christel Herold‐Mende, Mark R. Gilbert, Paras N. Prasad, Mioara Larion	52
12	Metabolic plasticity of IDH1-mutant glioma cell lines is responsible for low sensitivity to glutaminase inhibition 2020 ·SHILAP Revista de lepidopterología ·Victor Ruiz‐Rodado, Adrian Lita, Tyrone Dowdy, Orieta Celiku, (unknown), Herui Wang, Chunzhang Yang, Raj Chari, Aiguo Li, Wei Zhang, Hua Song, Meili Zhang, Susie Ahn, Dionne Davis, Xiang Chen, Zhengping Zhuang, Christel Herold‐Mende, Kylie J. Walters, Mark R. Gilbert, Mioara Larion	14
13	Sphingolipid Pathway as a Source of Vulnerability in IDH1mut Glioma 2020 ·Cancers ·Tyrone Dowdy, Lumin Zhang, Orieta Celiku, (unknown), Adrian Lita, Victor Ruiz‐Rodado, Mark R. Gilbert, Mioara Larion	23
14	Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma 2019 ·Cancer Research ·Jinkyu Jung, Ying Zhang, Orieta Celiku, Wei Zhang, Hua Song, Brian J. Williams, Amber Giles, Jeremy N. Rich, Roger Abounader, Mark R. Gilbert, Deric M. Park	69
15	Computational modeling demonstrates that glioblastoma cells can survive spatial environmental challenges through exploratory adaptation 2019 ·Nature Communications ·Orieta Celiku, Mark R. Gilbert, Orit Lavi	17
16	Computational analysis of the mesenchymal signature landscape in gliomas 2017 ·BMC Medical Genomics ·Orieta Celiku, Anita Tandle, Joon‐Yong Chung, Stephen M. Hewitt, Kevin Camphausen, Uma Shankavaram	2
17	Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins 2015 ·Molecular Cancer Research ·Uday Bhanu Maachani, Tamalee Kramp, Ryan Hanson, Shuping Zhao, Orieta Celiku, Uma Shankavaram, Riccardo Colombo, Natasha J. Caplen, Kevin Camphausen, Anita Tandle	46
18	Visualizing Molecular Profiles of Glioblastoma with GBM-BioDP 2014 ·PLoS ONE ·Orieta Celiku, (unknown), Shuping Zhao, Kevin Camphausen, Uma Shankavaram	48
19	Using Service-Oriented Architectures for Socio-Cultural Analysis 2009 ·Software Engineering and Knowledge Engineering ·David Garlan, Kathleen M. Carley, Bradley Schmerl, Michael W. Bigrigg, Orieta Celiku	8
20	Cost-based analysis of probabilistic programs mechanised in HOL 2004 ·Nordic journal of computing ·Orieta Celiku, Annabelle McIver	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact